Tachykinin neurokinin 3 receptor signaling in cholecystokinin-elicited release of oxytocin and vasopressin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 5, 2008, Pages

  Haley, Gwendolen E ^a   Flynn, Francis W ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Oxytocin; Vasopressin

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; N (ALPHA ETHYLBENZYL) 3 METHYL 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 3 RECEPTOR; OXYTOCIN; VASOPRESSIN; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; TETRAGASTRIN; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; HYPOPHYSIS; MALE; MEAN ARTERIAL PRESSURE; NEUROENDOCRINOLOGY; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CHOLECYSTOKININ; DATA INTERPRETATION, STATISTICAL; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; OXYTOCIN; PITUITARY GLAND; RATS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, NEUROKININ-3; SINCALIDE; TETRAGASTRIN; VASOPRESSINS;

EID: 45549089266     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00033.2008     Document Type: Article

References (69)

1. Abelson JL, Le Melledo JM, Bichet DG. Dose response of arginine vasopressin to the CCK-B agonist pentagastrin. Neuropsychopharmacology 24: 161-169, 2001.
2. Akins VF, Bealer SL. Central nervous system histamine regulates peripheral sympathetic activity. Am J Physiol Heart Circ Physiol 260: H218-H224, 1991.
3. Akins VF, Bealer SL. Hypothalamic histamine release, neuroendocrine and cardiovascular responses during tuberomammillary nucleus stimulation in the conscious rat. Neuroendocrinology 57: 849-855, 1993.
4. Armstrong WE, Gallagher MJ, Sladek CD. Noradrenergic stimulation of supraoptic neuronal activity and vasopressin release in vitro: mediation by an α1 receptor. Brain Res 365: 192-197, 1986.
5. Bealer SL, Flynn FW. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine. Exp Neurol 184: 1027-1033, 2003.
6. Bittencourt JC, Benoit R, Sawchenko PE. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections. J Chem Neuroanat 4: 63-78, 1991.
7. Bondy CA, Jensen RT, Brady LS, Gainer H. Cholecystokinin evokes secretion of oxytocin and vasopressin from rat neural lobe independent of external calcium. Proc Natl Acad Sci USA 86: 5198-5201, 1989.
8. Boudaba C, Di S, Tasker JG. Presynaptic noradrenergic regulation of glutamate inputs to hypothalamic magnocellular neurons. J Neuroendocrinol 15: 803-810, 2003.
9. Boudaba C, Tasker JG. Intranuclear coupling of hypothalamic magnocellular nuclei by glutamate synaptic circuits. Am J Physiol Regul Integr Comp Physiol 291: R102-R111, 2006.
10. Brooks DP, Share L, Crofton JT. Central adrenergic control of vasopressin release. Neuroendocrinology 42: 416-420, 1986.
11. Buller KM, Day TA. Involvement of medullary catecholamine cells in neuroendocrine responses to systemic cholecystokinin. J Neuroendocrinol 8: 819-824, 1996.
12. Buller KM, Smith DW, Day TA. Differential recruitment of hypothalamic neuroendocrine and ventrolateral medulla catecholamine cells by non-hypotensive and hypotensive hemorrhages. Brain Res 834: 42-54, 1999.
13. Carpentier C, Baude A. Immunocytochemical localization of NK3 receptors in the dorsal vagal complex of rat. Brain Res 736: 327-331, 1996.
14. Carter DA, Lightman SL. A role for the area postrema in mediating cholecystokinin-stimulated oxytocin secretion. Brain Res 435: 327-330, 1987.
15. Crawley JN, Corwin RL. Biological actions of cholecystokinin. Peptides 15: 731-755, 1994.
16. Crofton JT, Share L. Osmotic control of vasopressin in male and female rats. Am J Physiol Regul Integr Comp Physiol 257: R738-R743, 1989.
17. Crowley WR, Parker SL, Armstrong WE, Spinolo LH, Grosvenor CE. Neurotransmitter and neurohormonal regulation of oxytocin secretion in lactation. Ann NY Acad Sci 652: 286-302, 1992.
18. Day HE, McKnight AT, Poat JA, Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33: 719-727, 1994.
19. Day TA, Randle JC, Renaud LP. Opposing alpha-beta-adrenergic mechanisms mediate dose-dependent actions of noradrenaline on supraoptic vasopressin neurones in vivo. Brain Res 358: 171-179, 1985.
20. Ding YQ, Lu BZ, Guan ZL, Wang DS, Xu JQ, Li J. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline. Neuroscience 91: 1077-1085, 1999.
21. Ding YQ, Shi J, Su LY, Xu JQ, Su CJ, Guo XE, Ju G. Intracerebroventricular injection of senktide-induced Fos expression in vasopressincontaining hypothalamic neurons in the rat. Brain Res 882: 95-102, 2000.
22. Everitt BJ, Hokfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11: 443-462, 1984.
23. Flanagan LM, Dohanics J, Verbalis JG, Stricker EM. Gastric motility and food intake in rats after lesions of hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 263: R39-R44, 1992.
24. 3H]pentagastrin. Peptides 4: 755-762, 1983.
25. Gibbs DM. Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress. Life Sci 35: 487-491, 1984.
26. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
27. Haley GE, Flynn FW. Agonist and hypertonic saline-induced trafficking of the NK3-receptors on vasopressin neurons within the paraventricular nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 290: R1242-R1250, 2006.
28. Haley GE, Flynn FW. Tachykinin NK3 receptor contribution to systemic release of vasopressin and oxytocin in response to osmotic and hypotensive challenge. Am J Physiol Regul Integr Comp Physiol 293: R931-R937, 2007.
29. Hashimoto H, Onaka T, Kawasaki M, Chen L, Mera T, Soya A, Saito T, Fujihara H, Sei H, Morita Y, Ueta Y. Effects of cholecystokinin (CCK)-8 on hypothalamic oxytocin-secreting neurons in rats lacking CCK-A receptor. Auton Neurosci 121: 16-25, 2005.
30. Hashimoto K, Murakami K, Takao T, Makino S, Sugawara M, Ota Z. Effect of acute ether or restraint stress on plasma corticotropin-releasing hormone, vasopressin and oxytocin levels in the rat. Acta Med Okayama 43: 161-167, 1989.
31. Howe HE, Somponpun SJ, Sladek CD. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. J Neurosci 24: 10103-10110, 2004.
32. Kiss A, Mikkelsen JD. Oxytocin-anatomy and functional assignments: a minireview. Endocr Regul 39: 97-105, 2005.
33. Kojima S, Ikeda M, Kamikawa Y. Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor- triggered serotonin release from guinea pig colonic mucosa. J Pharmacol Sci 98: 175-180, 2005.
34. Leibowitz SF, Eidelman D, Suh JS, Diaz S, Sladek CD. Mapping study of noradrenergic stimulation of vasopressin release. Exp Neurol 110: 298-305, 1990.
35. Leng G, Luckman SM, Dyball REJ, Dye S, Hamamura M. Inputs from the nucleus tractus solitarii to the magnocellular neurosecretory system. Regul Pept 45: 103-107, 1993.
36. Linden A, Sodersten P. Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats. Physiol Behav 48: 859-863, 1990.
37. Lucas LR, Hurley DL, Krause JE, Harlan RE. Localization of the tachykinin neurokinin B precursor peptide in rat brain by immunocytochemistry and in situ hybridization. Neuroscience 51: 317-345, 1992.
38. Luckman SM, Hamamura M, Antonijevic I, Dye S, Leng G. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion. Br J Pharmacol 110: 378-384, 1993.
39. McCann MJ, Verbalis JG, Stricker EM. LiCl and CCK inhibit gastic emptying and feeding and stimulate OT secretion in rats. Am J Physiol Regul Integr Comp Physiol 256: R463-R468, 1989.
40. Meister B, Broberger C, Villar MJ, Hokfelt T. Cholecystokinin B receptor gene expression in hypothalamic neurosecretory neurons after experimental manipulations. Neuroendocrinology 60: 458-469, 1994.
41. Mercer LD, Beart PM. Immunolocalization of CCK1R in rat brain using a new anti-peptide antibody. Neurosci Lett 359: 109-113, 2004.
42. Mercer LD, Le VQ, Nunan J, Jones NM, Beart PM. Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci Lett 293: 167-170, 2000.
43. Mileusnic D, Lee JM, Magnuson DJ, Hejna MJ, Krause JE, Lorens JB, Lorens SA. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 89: 1269-1290, 1999.
44. Miller TR, Bianchi BR, Witte DG, Lin CW. Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo. Regul Pept 43: 107-112, 1993.
45. Monnikes H, Lauer G, Arnold R. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex, and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770: 277-288, 1997.
46. Moran TH, Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286: G183-G188, 2004.
47. Moran TH, Robinson PH, Goldrich MS, McHugh PR. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362: 175-179, 1986.
48. Mosher JT, Johnson MF, Birkemo LS, Ervin GN. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning. Peptides 17: 483-488, 1996.
49. Nagashima A, Takano Y, Tateishi K, Matsuoka Y, Hamaoka T, Kamiya H. Cardiovascular roles of tachykinin peptides in the nucleus tractus solitarii of rats. Brain Res 487: 392-396, 1989.
50. Oliveira GR, Franci CR, Rodovalho GV, Franci JA, Morris M, Rocha MJ. Alterations in the central vasopressin and oxytocin axis after lesion of a brain osmotic sensory region. Brain Res Bull 63: 515-520, 2004.
51. Onaka T, Luckman SM, Antonijevic I, Palmer JR, Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience 66: 403-412, 1995.
52. Onaka T, Yagi K. Involvement of N-methyl-D- aspartic acid receptor activation in oxytocin and vasopressin release after osmotic stimuli in rats. J Neuroendocrinol 13: 166-174, 2001.
53. Polidori C, Saija A, Perfumi M, Costa G, Massi M. Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors. Neurosci Lett 103: 320-325, 1989.
54. Raby WN, Renaud LP. Dorsomedial medulla stimulation activates rat supraoptic oxytocin and vasopressin neurones through different pathways. J Physiol 417: 279-294, 1989.
55. Randle JC, Day TA, Jhamandas JH, Bourque CW, Renaud LP. Neuropharmacolgy of supraoptic nucleus neurons: norepinephrine and γ-aminobutyric acid receptors. Fed Proc 45: 2312-2317, 1986.
56. Raybould HE, Gayton RJ, Dockray GJ. Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat. J Neurosci 8: 3018-3024, 1988.
57. Rinaman L, Hoffman G, Dohanics J, Le W, Stricker EM, Verbalis JG. Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. J Comp Neurol 360: 246-256, 1995.
58. Saito A, Sankaran H, Goldfine ID, Williams JA. Cholecystokinin receptors in the brain: characterization and distribution. Science 208: 1155-1156, 1980.
59. Sarau HM, Griswold DE, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Webb EF, Martin LD, Legos JJ, Whitmore RG, Barone FC, Medhurst AD, Luttmann MA, Giardina GA, Hay DW. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK3 receptor antagonist. J Pharmacol Exp Ther 295: 373-381, 2000.
60. Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 257: 275-325, 1982.
61. Shughrue PJ, Lane MV, Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 372: 395-414, 1996.
62. Smith ME, Flynn FW. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK3 receptor agonist, senktide. J Comp Neurol 426: 413-428, 2000.
63. Ueta Y, Kannan H, Higuchi T, Negoro H, Yamashita H. CCK-8 excites oxytocin-secreting neurons in the paraventricular nucleus in rats: possible involvement of noradrenergic pathway. Brain Res Bull 32: 453-459, 1993.
64. 3H]cholecystokinin-8 as a radioligand. J Neurosci 4: 1021-1033, 1984.
65. Verbalis JG, McCann MJ, McHale CM, Stricker EM. Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety. Science 232: 1417-1419, 1986.
66. Verbalis JG, McHale CM, Gardiner TW, Stricker EM. Oxytocin and vasopressin secretion in response to stimuli producing learned taste aversions in rats. Behav Neurosci 100: 466-475, 1986.
67. Verbalis JG, Stricker EM, Robinson A, Hoffman G. Cholecystokinin activates c-Fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J Neuroendocrinol 3: 205-213, 1991.
68. Wisniewska RJ, Kupryszewski G. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats. Pol J Pharmacol Pharm 44: 281-287, 1992.
69. Yamaguchi K, Yamada T. Involvement of anteroventral third ventricular AMPA/kainate receptors in both hyperosmotic and hypovolemic AVP secretion in conscious rats. Brain Res Bull 71: 183-192, 2006.